Surviving and thriving in the cystic fibrosis lung: contribution of an arginine specific aminopeptidase to sustained infection by Pseudomonas aeruginosa

QR Code

Surviving and thriving in the cystic fibrosis lung: contribution of an arginine specific aminopeptidase to sustained infection by Pseudomonas aeruginosa

Pseudomonas aeruginosa is a prominent pathogen within the Cystic Fibrosis (CF) community which can survive the challenges posed by the immune system and antibiotic treatment in patient lungs. P. aeruginosa is such a success in this environment for numerous reasons that including (i) a multifactorial...

Full description

Bibliographic Details
Main Author:	Spencer, Daniella Lucy
Format:	Thesis (University of Nottingham only)
Language:	English
Published:	2019
Subjects:	Pseudomonas aeruginosa; Cystic Fibrosis; Arginine specific Autotransporter Aminopeptidase; Biofilm formation
Online Access:	https://eprints.nottingham.ac.uk/56270/

Similar Items

Lectin-mediated biofilm maturation, quorum sensing and Pseudomonas aeruginosa infections in cystic fibrosis
by: Crusz, S.A.
Published: (2009)

Characterising the role of potential accessory factors that facilitate secretion and gene regulation of the EspC and AaaA autotransporters
by: Alhagh, Mohammad Shakib
Published: (2021)

Mitigating the harm caused by Pseudomonas aeruginosa in Cystic Fibrosis
by: Palser, Sally C.
Published: (2024)

Exploring the structure, regulation, and function of the surface tethered Pseudomonas aeruginosa virulence factor, AaaA, and its role in maintaining chronic wound infections
by: Laxton, Claire. S.
Published: (2023)

In vitro study of effects of antibiotics on Pseudomonas aeruginosa biofilm formation
by: Jeevajothi Nathan, Priadarssini
Published: (2017)

An ex vivo lung model to study bronchioles infected with Pseudomonas aeruginosa biofilms
by: Harrison, Freya, et al.
Published: (2016)

Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis
by: Langton Hewer, Simon C., et al.
Published: (2014)

Novel approaches to the treatment of Pseudomonas aeruginosa infections in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)

Role of lectin receptors in recognition of Pseudomonas aeruginosa biofilms
by: Almuhanna, Yasir Saleh I
Published: (2021)

Results of antibiotic susceptibility testing do not influence clinical outcome in children with cystic fibrosis
by: Hurley, M.N., et al.
Published: (2012)

A phase 3, open-label, randomized trial to evaluate the safety and efficacy of levofloxacin inhalation solution (APT-1026) versus tobramycin inhalation solution in stable cystic fibrosis patients
by: Elborn, J. Stuart, et al.
Published: (2015)

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation solution (APT-1026) in stable cystic fibrosis patients
by: Flume, Patrick, et al.
Published: (2016)

Use of a primary epithelial cell screening tool to investigate phage therapy in cystic fibrosis
by: Trend, S., et al.
Published: (2018)

Biosurfactant Production by Pseudomonas Aeruginosa 181
by: Yassin Al-Araji, Laith Issa
Published: (2004)

Investigating the use of novel fluorescent nanosensors to measure chemical changes in bacterial surroundings
by: Perkins, Mark Edwin
Published: (2021)

Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium
by: Freschi, Luca, et al.
Published: (2015)

Delayed publications of clinical trials in cystic fibrosis
by: Hurley, M.N., et al.
Published: (2011)

Glutamine supplementation in cystic fibrosis: a randomized placebo-controlled trial
by: Forrester, Doug L., et al.
Published: (2015)

Investigating microbial biofilms within washing machines: novel nanosensor technology enables insights into pH gradients of Pseudomonas aeruginosa biofilms
by: Hollmann, Birte
Published: (2021)

Production and characterization of biosurfactant by isolated Pseudomonas aeruginosa RS6 strain
by: Nordin, Nordiyana
Published: (2016)

European Cystic Fibrosis Society standards of care: best practice guidelines
by: Smyth, Alan R., et al.
Published: (2014)

Xbox Kinect™ represents high intensity exercise for adults with cystic fibrosis
by: Holmes, H., et al.
Published: (2013)

Understanding chronic inflammatory diseases in the human lung: the cystic fibrosis and idiopathic pulmonary fibrosis paradigms
by: Liu, Yi-Chia
Published: (2014)

Cystic Fibrosis isolates of Pseudomonas aeruginosa retain iron-regulated antimicrobial activity against Staphylococcus aureus through the action of multiple alkylquinolones
by: Nguyen, Angela T., et al.
Published: (2016)

Identifying peroxidases and their oxidants in the early pathology of cystic fibrosis.
by: Thomson, E., et al.
Published: (2010)

Characterization of an Organic Solvent-Tolerant Protease from Pseudomonas Aeruginosa Strain K
by: Lee, Poh Geok
Published: (2003)

Early respiratory bacterial detection and anti-staphylococcal antibiotic prophylaxis in young children with cystic fibrosis
by: Hurley, Matthew, et al.
Published: (2017)

Understanding the Costs of Care for Cystic Fibrosis: an Analysis by Age and Health State
by: Van Gool, K., et al.
Published: (2013)

Cost-Effectiveness of Carrier Screening for Cystic Fibrosis in Australia
by: Norman, Richard, et al.
Published: (2012)

Production of biosurfactant from biodiesel side-stream glycerine by Pseudomonas aeruginosa RS6
by: Baskaran, Shobanah Menon
Published: (2020)

PQS-dependent quorum sensing in pseudomonas aeruginosa is linked to protein export via the twin-arginine translocation (tat) system
by: Smith, Frances
Published: (2022)

Prevalence of metallo-Beta-lactamase producing Pseudomonas aeruginosa in a tertiary care at Hospital Kuala Lumpur, Malaysia
by: Idris, Siti Nur Atiqah
Published: (2016)

SadB is a Pseudomonas aeruginosa global regulator
by: Papangeli, Maria
Published: (2022)

The pharmacokinetics and toxicity of morning vs. evening tobramycin dosing for pulmonary exacerbations of cystic fibrosis: a randomised comparison
by: Prayle, A.P., et al.
Published: (2015)

Search for Pseudomonas aeruginosa immune-modulatory but non-inducing agents
by: Jadhav, Gopal P.
Published: (2008)

The top 10 research priorities in cystic fibrosis developed by a partnership between people with CF and health care providers
by: Rowbotham, Nicola J., et al.
Published: (2017)

Antimicrobial and anti-quorum sensing activties of javanese turmeric (Curcuma xanthorrhiza Roxb.) ethanolic extract against Pseudomonas aeruginosa
by: Othman, Ahmad Fiqri Mustaqim
Published: (2018)

Prevention of treatment related adverse effects in cystic fibrosis
by: Jain, Kamini
Published: (2018)

High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection
by: Monaghan, Tanya M., et al.
Published: (2017)

Interventions for the eradication of meticillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis
by: Smyth, Alan R.
Published: (2015)